. 2012 Sep 22;11(12):1898–1912. doi: 10.1074/mcp.M112.019661

Table II. Effective dose 50% (ED₅₀) of ATO, ODPC, or perifosine for the inhibition of the proliferation of NB4 wild type (NB4 WT) and LAT2 knockdown NB4 (NB4 LAT2KD) cells.

	NB4 WT			NB4 LAT2KD			Relative drug susceptibility^a
	ED₅₀ (μm)	95% CI^b	r	ED₅₀ (μm)	95% CI^b	r	NB4 WT/NB4 LAT2KD
ATO	8.76	5.36 to 14.34	0.94	1.03	0.92 to 1.15	0.98	8.50
ODPC	23.49	19.79 to 27.88	0.95	3.12	1.83 to 5.28	0.92	7.53
Perifosine	18.67	16.48 to 21.17	0.97	6.10	4.45 to 8.37	0.91	3.06

^a Ratio calculated by averaging ED₅₀.

^b 95% CI is the 95% confidence interval for ED₅₀, expressed in μm.

Table II. Effective dose 50% (ED50) of ATO, ODPC, or perifosine for the inhibition of the proliferation of NB4 wild type (NB4 WT) and LAT2 knockdown NB4 (NB4 LAT2KD) cells.